PerkinElmer (PKI) Receives Daily News Impact Score of 0.13
Headlines about PerkinElmer (NYSE:PKI) have trended somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. PerkinElmer earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 45.7120740403032 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the media headlines that may have effected Accern’s scoring:
- ETFs with exposure to PerkinElmer, Inc. (United States) : October 3, 2017 (finance.yahoo.com)
- PerkinElmer, Inc. (PKI) Expected to Post Earnings of $0.73 Per Share (americanbankingnews.com)
- PerkinElmer, Inc. (United States) :PKI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 2, 2017 (finance.yahoo.com)
- Goldman Sachs Group, Inc. (The) Reiterates “Neutral” Rating for PerkinElmer, Inc. (PKI) (americanbankingnews.com)
- Brokerages Anticipate PerkinElmer, Inc. (PKI) Will Post Quarterly Sales of $552.30 Million (americanbankingnews.com)
Shares of PerkinElmer (NYSE:PKI) opened at 70.61 on Friday. The stock has a market cap of $7.78 billion, a price-to-earnings ratio of 21.29 and a beta of 0.72. The company has a 50 day moving average of $67.73 and a 200-day moving average of $64.36. PerkinElmer has a one year low of $45.35 and a one year high of $70.61.
PerkinElmer (NYSE:PKI) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.67 EPS for the quarter, hitting analysts’ consensus estimates of $0.67. The firm had revenue of $547.00 million during the quarter, compared to analysts’ expectations of $554.14 million. PerkinElmer had a return on equity of 13.44% and a net margin of 16.80%. The firm’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.67 EPS. On average, analysts anticipate that PerkinElmer will post $2.89 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, October 20th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date of this dividend is Thursday, October 19th. PerkinElmer’s dividend payout ratio is presently 8.46%.
A number of equities research analysts have recently issued reports on the stock. Cowen and Company reaffirmed a “market perform” rating and set a $70.00 target price (up previously from $61.00) on shares of PerkinElmer in a report on Tuesday, June 20th. Wells Fargo & Company assumed coverage on shares of PerkinElmer in a report on Thursday, July 13th. They set a “market perform” rating and a $72.00 target price for the company. Zacks Investment Research lowered shares of PerkinElmer from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $67.00 target price on shares of PerkinElmer in a report on Tuesday, September 26th. Finally, BidaskClub lowered shares of PerkinElmer from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company’s stock. PerkinElmer currently has a consensus rating of “Hold” and a consensus target price of $67.77.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.